Hi ,
|
The synthetic biology ecosystem has slowly evolved to include more women, but still women are underrepresented as founders, investors and board members. If you couldn't make it to SynBioBeta this year, check out this video, "Opportunities & Challenges for Women Founders & Investors in Synthetic Biology." The panelists shared how they successfully achieved their goals, and what they learned along the way.
|
 |
Milana Boukhman Trounce of Stanford University, Karyn Riegel of Leaps by Bayer, and Natalie Kuldell of BioBuilder at SynBioBeta 2022.
Congratulations to Terri Shieh-Newton, PhD for being named as one of the 2022 "Top 250 Women in IP" by Managing IP. You can meet Terri and many other key movers and shakers of the industry at our flagship event at the Oakland
Marriott, May 23-25, 2023. Tickets went on sale this week!
|
 |
Last March, researchers at Lumen Bioscience published a paper in Nature Biotechnology. Now, they are excited to share that this work is a featured cover for the newest Nature Biotechnology issue.
|
 |
It's great to see a newly announced collaboration of two Leaps by Bayer portfolio companies, Affini-T Therapeutics and Metagenomi, to create new opportunities for cancer patients by combining Metagenomi’s gene editing systems and Affini-T’s TCR discovery and synthetic biology platform.
In other news, ResVita Bio received Rare Pediatric Disease Designation for RVB-001 as a Treatment for Netherton Syndrome. Through synthetic biology and metabolic engineering, they are developing a skin probiotic platform to deliver therapies that directly treat inflammatory skin diseases.
Umaro Foods is launching its seaweed-based bacon into three US restaurants, marking the first time consumers can try the brand’s innovative protein.
|
 |
|
|
|
|
 |
Clean and green: Unilever and Geno launch $120m palm oil alternatives venture |
Unilever and U.S. biotech company Genomatica (Geno) are working on a plan to scale and commercialize alternatives to palm oil and fossil fuel-derived cleansing ingredients.
|
Keep Reading »
|
|
 |
Shedding light on how bacteria communicate their way to causing infection |
Oregon State University scientists have identified proteins that prevent a bacterial cell from becoming misguided by its own messaging, allowing it to instead wait for collective communication from its group.
|
Keep Reading »
|
|
|
 |
Download the application note to learn how Inscripta’s OnyxTM Digital Genome Engineering Platform can be used for rapid protein engineering to optimize activity, function, and expression.
|
Keep Reading »
|
|
 |
New designer cells could advance treatments for illness and disease |
Artificial cells have been engineered to mimic the natural characteristics of biological cells in a new novel study from Imperial College London.
|
Keep Reading »
|
|
|
Other News
|
- New microchip based on biomolecules is no alien technology. Roswell Biotechnologies wants you to believe its new chip will revolutionize the detection of viruses, DNA, and more. But it still has to prove itself.
- Slingshot Biosciences partners With Cambridge Bioscience to distribute synthetic cells Throughout United Kingdom and Ireland and with Kem-En-Tec Nordic A/S to distribute cells throughout Denmark, Sweden, Norway, Finland, and Iceland.
- CHAIN Biotech and the University of Oxford collaborate to tackle oral vaccine inequality. CHAIN Biotech has developed a platform for oral drug delivery, based on living gutbacteria, engineered to
deliver specific therapeutic cargo to the lower gastrointestinal tract.
- Children to get CRISPR treatment for sickle cell disease in trial. The aim is to treat children early enough to prevent them getting lasting damage from beta thalassaemia and sickle cell disease.
- Can synthetic biology and pond scum deliver carbon-neutral manufacturing? Provectus Algae is developing technologies to grow microalgae at scale and engineer them to produce diverse biomaterials such as food additives, cosmetics, and fragrances.
- A global forum on synthetic biology: the need for international engagement. The international community needs a global confidence-building measure focused on discussing policy futures for the age of engineering biology.
- Cronos Group and Ginkgo Bioworks announce achievement of THCV equity milestone. Using Ginkgo's platform for organism design and development, Cronos has successfully achieved
the productivity target for THCV, a cannabinoid.
|
|
|
Who's hiring?
|
- Account Executive - East Coast, Inscripta, East Coast
- Senior Lab Automation Systems Engineer, Inscripta, Pleasanton, CA
- Research Associate, Inscripta, Boulder, CO
- Scientist / Senior Scientist, Stemloop, Evanston, IL
- Engineering Technician, Inscripta, Pleasanton, CA
|
|
|
